HEIDELBERG, 20 January 2014 – Scientists from the Montreal Neurological Institute and Hospital in Canada have discovered that two genes linked to hereditary Parkinson's disease are involved in the early-stage quality control of mitochondria. The protective mechanism, which is reported in The EMBO Journal, removes damaged proteins that arise from oxidative stress from mitochondria.
"PINK1 and parkin, are implicated in selectively targeting dysfunctional components of mitochondria to the lysosome under conditions of excessive oxidative damage within the organelle," said Edward Fon, Professor at the McGill Parkinson Program at the Montreal Neurological Institute and Hospital. "Our study reveals a quality control mechanism where vesicles bud off from mitochondria and proceed to the lysosome for degradation. This method is distinct from the degradation pathway for damaged whole mitochondria which has been known for some time. It is also an early response, proceeding on a timescale of hours instead of days."
The deterioration of mechanisms designed to maintain the integrity and function of mito-chondria throughout the lifetime of a cell has been suggested to underlie the progression of several neurodegenerative diseases, including Parkinson's disease. When mitochon-dria, the "power plants" of the cell that provide energy, malfunction they can contribute to Parkinson's disease. If they are to survive and function mitochondria need to degrade oxidized and damaged proteins.
In the study, immunofluorescence and confocal microscopy were used to observe how the vesicles "pinch off" from mitochondria with their damaged cargo. "Our conclusion is that the loss of this PINK1 and parkin-dependent trafficking system impairs the ability of mitochondria to selectively degrade oxidized and damaged proteins and leads, over time, to the mitochondrial dysfunction noted in hereditary Parkinson's disease," said Hei-di McBride, Professor in the Neuromuscular Group in the Department of Neurology and Neurosurgery at the Montreal Neurological Institute and Hospital. Both salvage pathways are operational in the cell. If the vesicular pathway, the first line of defense, is overwhelmed and the damage is irreversible then the entire organelle is targeted for degradation.
Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochon-drial quality control
Gian-Luca McLelland, Vincent Soubannier, Carol X Chen, Heidi M. McBride, Edward A. Fon
Read the paper: http://emboj.embopress.org/content/early/2014/01/20/embj.201385902 doi: 10.1002/embj.201385902
Further information on The EMBO Journal is available at http://emboj.embopress.org/
Media Contacts
Barry Whyte
Head | Public Relations and Communications
barry.whyte@embo.org
Andrea Leibfried
Editor, The EMBO Journal
Tel: +49 6221 8891 417
a.leibfried@embojournal.org
About EMBO
EMBO is an organization of more than 1600 leading researchers that promotes excel-lence in the life sciences. The major goals of the organization are to support talented re-searchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work.
EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and re-search policy by seeking input and feedback from our community and by following close-ly the trends in science in Europe.
For more information: http://www.embo.org
Journal
The EMBO Journal